These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 29712716)
1. Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPARγ activity. Kurano M; Ikeda H; Iso-O N; Hara M; Tsukamoto K; Yatomi Y Biochem J; 2018 Jun; 475(12):2009-2024. PubMed ID: 29712716 [TBL] [Abstract][Full Text] [Related]
3. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237 [TBL] [Abstract][Full Text] [Related]
4. Protection Against Insulin Resistance by Apolipoprotein M/Sphingosine-1-Phosphate. Kurano M; Tsukamoto K; Shimizu T; Kassai H; Nakao K; Aiba A; Hara M; Yatomi Y Diabetes; 2020 May; 69(5):867-881. PubMed ID: 31915150 [TBL] [Abstract][Full Text] [Related]
5. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881 [TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis. Parham KA; Zebol JR; Tooley KL; Sun WY; Moldenhauer LM; Cockshell MP; Gliddon BL; Moretti PA; Tigyi G; Pitson SM; Bonder CS FASEB J; 2015 Sep; 29(9):3638-53. PubMed ID: 25985799 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate. Sutter I; Park R; Othman A; Rohrer L; Hornemann T; Stoffel M; Devuyst O; von Eckardstein A J Lipid Res; 2014 Aug; 55(8):1730-7. PubMed ID: 24950692 [TBL] [Abstract][Full Text] [Related]
8. Modulation of sphingosine 1-phosphate by hepatobiliary cholesterol handling. Kurano M; Tsukamoto K; Hara M; Tsuneyama K; Nishikawa T; Ikeda H; Yatomi Y FASEB J; 2020 Nov; 34(11):14655-14670. PubMed ID: 32918529 [TBL] [Abstract][Full Text] [Related]
9. A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation. Hajny S; Christoffersen C Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749426 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes. Christensen PM; Bosteen MH; Hajny S; Nielsen LB; Christoffersen C Sci Rep; 2017 Nov; 7(1):14983. PubMed ID: 29118354 [TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons. Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127 [TBL] [Abstract][Full Text] [Related]
12. Resveratrol exerts a biphasic effect on apolipoprotein M. Kurano M; Hara M; Nojiri T; Ikeda H; Tsukamoto K; Yatomi Y Br J Pharmacol; 2016 Jan; 173(1):222-33. PubMed ID: 26445217 [TBL] [Abstract][Full Text] [Related]
13. Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate. Kurano M; Hara M; Tsuneyama K; Sakoda H; Shimizu T; Tsukamoto K; Ikeda H; Yatomi Y Biochim Biophys Acta; 2014 Sep; 1841(9):1217-26. PubMed ID: 24814049 [TBL] [Abstract][Full Text] [Related]
14. Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice. Obinata H; Kuo A; Wada Y; Swendeman S; Liu CH; Blaho VA; Nagumo R; Satoh K; Izumi T; Hla T J Lipid Res; 2019 Nov; 60(11):1912-1921. PubMed ID: 31462513 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein M Inhibits Angiogenic and Inflammatory Response by Sphingosine 1-Phosphate on Retinal Pigment Epithelium Cells. Terao R; Honjo M; Aihara M Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29301231 [TBL] [Abstract][Full Text] [Related]
16. Sphingosine 1-Phosphate and Atherosclerosis. Kurano M; Yatomi Y J Atheroscler Thromb; 2018 Jan; 25(1):16-26. PubMed ID: 28724841 [TBL] [Abstract][Full Text] [Related]
17. Berberine reduces gut-vascular barrier permeability via modulation of ApoM/S1P pathway in a model of polymicrobial sepsis. Li Y; Zhou J; Qiu J; Huang Z; Wang W; Wu P; Feng A Life Sci; 2020 Nov; 261():118460. PubMed ID: 32961234 [TBL] [Abstract][Full Text] [Related]
18. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252 [TBL] [Abstract][Full Text] [Related]
19. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Blaho VA; Galvani S; Engelbrecht E; Liu C; Swendeman SL; Kono M; Proia RL; Steinman L; Han MH; Hla T Nature; 2015 Jul; 523(7560):342-6. PubMed ID: 26053123 [TBL] [Abstract][Full Text] [Related]
20. Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway. Izquierdo MC; Shanmugarajah N; Lee SX; Kraakman MJ; Westerterp M; Kitamoto T; Harris M; Cook JR; Gusarova GA; Zhong K; Marbuary E; O-Sullivan I; Rasmus N; Camastra S; Unterman TG; Ferrannini E; Hurwitz BE; Haeusler RA J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35104242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]